UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001790
Receipt number R000002156
Scientific Title Topical dexamethasone aqueous solution for macular edema
Date of disclosure of the study information 2009/03/25
Last modified on 2019/04/02 07:22:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Topical dexamethasone aqueous solution for macular edema

Acronym

Topical dexamethasone aqueous solution for macular edema

Scientific Title

Topical dexamethasone aqueous solution for macular edema

Scientific Title:Acronym

Topical dexamethasone aqueous solution for macular edema

Region

Japan


Condition

Condition

macular edema

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To test the efficacy of topical cyclodextrin-dexamethansone solution for macular edema

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

visual acuity, macular thickness

Key secondary outcomes

IOP, adrenal function, blood sugar


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

cyclodextrin dexamethasone eye drops (pilot study)

Interventions/Control_2

cyclodextrin dexamethasone eye drops

Interventions/Control_3

Triamcinolone acetonide sub-Tenon injection

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Macular edema subsequent to diabetic retinopathy, retinal vein occlusion, and uveitis.

Key exclusion criteria

The patients who do not agree with participation to the study.

Target sample size

90


Research contact person

Name of lead principal investigator

1st name Masaki
Middle name
Last name Tanito

Organization

Shimane University Faculty of Medicine

Division name

Ophthalmology

Zip code

6938501

Address

Enya 89-1, Izumo

TEL

0853202284

Email

tanito-oph@umin.ac.jp


Public contact

Name of contact person

1st name Masaki
Middle name
Last name Tanito

Organization

Shimane University Faculty of Medicine

Division name

Ophthalmology

Zip code

6938501

Address

89-1 Tenjin, Izumo

TEL

0853202284

Homepage URL


Email

tanito-oph@umin.ac.jp


Sponsor or person

Institute

Departmet of Ophthalmology, Shimane University Faculty of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shimane University faculty of Medicine

Address

89-1 Tenjin, Izumo

Tel

0853-20-2111

Email

kodama@jn.shimane-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 03 Month 25 Day


Related information

URL releasing protocol

https://www.med.shimane-u.ac.jp/ophthalmology/

Publication of results

Unpublished


Result

URL related to results and publications

https://www.med.shimane-u.ac.jp/ophthalmology/

Number of participants that the trial has enrolled

0

Results

NA

Results date posted

2019 Year 04 Month 02 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

NA

Participant flow

NA

Adverse events

NA

Outcome measures

NA

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2008 Year 07 Month 28 Day

Date of IRB

2009 Year 03 Month 01 Day

Anticipated trial start date

2009 Year 03 Month 01 Day

Last follow-up date

2012 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2009 Year 03 Month 23 Day

Last modified on

2019 Year 04 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002156


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name